Published in Vaccine Weekly, October 16th, 1995
Previous research has shown that liposomes can effectively be used as adjuvants to stimulate humoral and cellular specific immune responses of tumor vaccines. O. Masso et al. submitted research to the 1994 International Symposium on Cancer Vaccines showing that the use of liposomes increases the immunogenicity of weakly immunogenic tumor vaccines.
S.F. Alino et al., from the University of Valencia, Spain, explored additional methods of improving liposome adjuvant methods of boosting...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.